Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer
Article in Lung Cancer (August 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Lung Cancer (August 2024)
Article in Advances in Therapy (June 2024)
Article in ESMO Open (November 2023)